Skip to main content

Published locations for Combination of time-limited ibrutinib and chimeric antigen receptor T-cells shows promise in r/r MCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Combination of time-limited ibrutinib and chimeric antigen receptor T-cells shows promise in r/r MCL

User login

  • Reset your password
  • /content/combination-time-limited-ibrutinib-and-chimeric-antigen-receptor-t-cells-shows-promise-r/r
  • /content/combination-time-limited-ibrutinib-and-chimeric-antigen-receptor-t-cells-shows-promise-r/r-mcl
  • /b-cell-lymphoma-icymi/article/266589/b-cell-lymphoma/combination-time-limited-ibrutinib-and-chimeric